Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin protein domains form the tripartite structure of keratins—head, central rod (with coiled-coil subdomains 1A, 1B, 2A, 2B, and linkers L1, L12, L2), and tail—that enable these type I and type II intermediate filament proteins to assemble into 10-nm filaments providing cytoskeletal integrity in epithelial tissues like skin, hair, and nails.[1][2][3] The rod domain drives dimerization and higher-order filament formation through parallel heterodimer coiled-coils, while variable head and tail domains facilitate interactions, compaction, and non-mechanical roles such as signaling.[1][5][9] Mutations disrupting domain assembly cause fragility disorders like epidermolysis bullosa.[9] No drugs directly target these domains therapeutically; research focuses on structural biology rather than pharmacology.[1][2] Keratins are not receptors or enzymes but structural scaffolds essential for epithelial barrier function.[2][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin protein domains.